+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Organic Pharmaceutical Excipients Market - Global Forecast 2026-2032- Product Image
Organic Pharmaceutical Excipients Market - Global Forecast 2026-2032- Product Image
New

Organic Pharmaceutical Excipients Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 194 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4807793
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Organic pharmaceutical excipients are increasingly recognized as strategic building blocks for drug manufacturers working to meet new standards in safety, performance, and compliance. As the landscape grows more complex, choosing the right excipients is essential for operational reliability and effective global market participation.

Market Snapshot: Organic Pharmaceutical Excipients Market

The Organic Pharmaceutical Excipients Market is experiencing strong expansion, with value projections moving from USD 13.80 billion in 2025 to USD 15.09 billion in 2026 and reaching USD 27.05 billion by 2032. This reflects a CAGR of 10.08%, highlighting the market’s momentum as a result of portfolio diversification and emerging regulatory priorities. Innovations in material science, the evolution of analytical platforms, and an expanding need for sustainability and transparency are key contributors. These trends underline how excipients not only influence formulation quality but also underpin organizational stability and supply chain performance throughout global pharmaceutical operations.

Scope & Segmentation of the Organic Pharmaceutical Excipients Market

  • Segment Types: Includes cellulose derivatives such as hydroxypropyl methylcellulose and microcrystalline cellulose, along with starches from corn and potato, sugars and polymers like lactose, mannitol, sucrose, and gelatin, as well as inorganic salts such as calcium phosphate and magnesium stearate. Each group addresses diverse formulation challenges and specific quality targets in drug development.
  • Application Modalities: Encompasses oral solid dosages (tablets, capsules), injectable drugs, ophthalmic products, and topical formulations, each requiring distinct functional properties and purity profiles to assure therapeutic efficacy and patient safety.
  • Physical Forms: Delivered as powders, granules, gels, and liquids, with each format demanding tailored processing, handling, and validation steps to mitigate risks in the manufacturing environment.
  • Raw Material Origins: Draws from natural sources, semi-synthetic, and synthetic materials; each origin brings implications for market compliance, environmental initiatives, and supply continuity amid geographic or seasonal fluctuations.
  • Regional Coverage: Explores the Americas, Europe, Middle East and Africa, and Asia Pacific, acknowledging the variations in manufacturing capabilities, compliance regimes, and supply infrastructure that shape local and global procurement dynamics.
  • Technology Adoption: Spotlights the increasing use of digital traceability tools, advanced analytics, and predictive models to advance excipient qualification and reinforce regulatory compliance efforts.

Key Takeaways for Senior Decision-Makers

  • Excipients are integral to both regulatory frameworks and daily operations, necessitating strong alignment between cross-disciplinary teams to address complexity and maintain product quality.
  • Supplier landscapes are shifting, with organizations reevaluating sourcing arrangements to adapt to sustainability mandates, employing strategies such as dual-sourcing and nearshoring to preserve security of supply.
  • Advanced analytics paired with digital supply chain technologies are enabling better traceability, offering clarity from procurement through production and fostering a proactive approach to risk.
  • Evaluating raw material origins, impurity profiles, and environmental standards is increasingly influencing how organizations manage supplier approval and partnership structures across key markets.
  • Strategic investment in robust formulation design and contingency planning for excipient substitution can prevent downstream regulatory challenges and contain the risk associated with material variability or obsolescence.

Tariff Impact: Navigating New Sourcing Realities

Current U.S. tariff measures are adding further complexity to how pharmaceutical manufacturers structure excipient sourcing and cost containment. Companies are responding by broadening supplier networks and adopting dual-source strategies for vital components, as well as updating contracts to address tariff exposure. Many are also weighing the benefits of inventory buffers and nearshoring options, alongside increased investment in supplier development programs. All adjustments must be rigorously aligned with internal quality management systems to minimize operational risks.

Methodology & Data Sources

This analysis draws on structured interviews with subject-matter experts in formulation, procurement, supply chain management, and regulatory compliance. Findings are corroborated using technical evaluations, up-to-date regulatory filings, and supplier quality data. Scenario planning is conducted to tailor recommendations for varied operational and global disruption contexts.

Why This Report Matters

  • Enables executive teams to link excipient selection with evolving regulatory, operational, and commercial requirements across multiple business functions.
  • Offers real-world insights for adapting sourcing and supplier relationships, supporting risk-managed decisions amid global supply chain disruptions.
  • Supplies strategic, targeted intelligence on new technology applications, sustainability trends, and region-specific challenges to guide competitive product and portfolio management.

Conclusion

Effective management of pharmaceutical excipients requires integrated planning and collaborative supplier partnerships. By prioritizing analytical advancements and robust governance, industry leaders can reinforce adaptability and compliance in today’s rapidly changing market environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Organic Pharmaceutical Excipients Market, by Product Type
8.1. Cellulose Derivatives
8.1.1. Hydroxypropyl Methylcellulose
8.1.2. Microcrystalline Cellulose
8.2. Gelatin
8.3. Inorganic Salts
8.3.1. Calcium Phosphate
8.3.2. Magnesium Stearate
8.4. Starches And Dextrins
8.4.1. Corn Starch
8.4.2. Potato Starch
8.5. Sugars And Polymers
8.5.1. Lactose
8.5.2. Mannitol
8.5.3. Sucrose
9. Organic Pharmaceutical Excipients Market, by Application
9.1. Injectable
9.2. Ophthalmic
9.3. Oral Solid Dosage
9.3.1. Capsules
9.3.2. Tablets
9.4. Topical
10. Organic Pharmaceutical Excipients Market, by Form
10.1. Gel
10.2. Granule
10.3. Liquid
10.4. Powder
11. Organic Pharmaceutical Excipients Market, by Source
11.1. Natural
11.2. Semi Synthetic
11.3. Synthetic
12. Organic Pharmaceutical Excipients Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Organic Pharmaceutical Excipients Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Organic Pharmaceutical Excipients Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Organic Pharmaceutical Excipients Market
16. China Organic Pharmaceutical Excipients Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Archer Daniels Midland Company
17.6. Ashland Global Holdings Inc.
17.7. Associated British Foods plc
17.8. BASF SE
17.9. Cargill Incorporated
17.10. Croda International Plc
17.11. DFE Pharma International Ltd.
17.12. DuPont de Nemours Inc.
17.13. Evonik Industries AG
17.14. Gattefossé SAS
17.15. Ingredion Incorporated
17.16. Innophos Holdings, Inc.
17.17. International Flavors & Fragrances Inc.
17.18. JRS Pharma GmbH & Co. KG
17.19. Kerry Group Plc
17.20. Merck KGaA
17.21. Roquette Frères S.A.
17.22. Shin-Etsu Chemical Co., Ltd.
17.23. The Lubrizol Corporation
17.24. Wacker Chemie AG
List of Figures
FIGURE 1. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY HYDROXYPROPYL METHYLCELLULOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MICROCRYSTALLINE CELLULOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELATIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELATIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GELATIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CALCIUM PHOSPHATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MAGNESIUM STEARATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MAGNESIUM STEARATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MAGNESIUM STEARATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CORN STARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CORN STARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CORN STARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POTATO STARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POTATO STARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POTATO STARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LACTOSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUCROSE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUCROSE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUCROSE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OPHTHALMIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY OPHTHALMIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GRANULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GRANULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY NATURAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEMI SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEMI SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SEMI SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 133. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 135. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 136. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2032 (USD MILLION)
TABLE 137. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2032 (USD MILLION)
TABLE 138. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2032 (USD MILLION)
TABLE 139. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 140. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 141. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 142. EUROPE ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 153. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 156. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2032 (USD MILLION)
TABLE 157. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2032 (USD MILLION)
TABLE 158. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2032 (USD MILLION)
TABLE 159. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 161. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 162. AFRICA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 176. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 177. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2032 (USD MILLION)
TABLE 178. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2032 (USD MILLION)
TABLE 179. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2032 (USD MILLION)
TABLE 180. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 181. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 182. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 183. ASEAN ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 184. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 187. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2032 (USD MILLION)
TABLE 188. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2032 (USD MILLION)
TABLE 189. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2032 (USD MILLION)
TABLE 190. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 192. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 193. GCC ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 204. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 206. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 207. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2032 (USD MILLION)
TABLE 208. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2032 (USD MILLION)
TABLE 209. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2032 (USD MILLION)
TABLE 210. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 211. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 212. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 213. BRICS ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 214. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 215. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 216. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 217. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2032 (USD MILLION)
TABLE 218. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2032 (USD MILLION)
TABLE 219. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2032 (USD MILLION)
TABLE 220. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 221. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 222. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 223. G7 ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 224. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 225. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 226. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 227. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2032 (USD MILLION)
TABLE 228. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2032 (USD MILLION)
TABLE 229. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2032 (USD MILLION)
TABLE 230. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 232. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 233. NATO ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 234. GLOBAL ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
TABLE 245. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 246. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 247. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CELLULOSE DERIVATIVES, 2018-2032 (USD MILLION)
TABLE 248. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY INORGANIC SALTS, 2018-2032 (USD MILLION)
TABLE 249. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCHES AND DEXTRINS, 2018-2032 (USD MILLION)
TABLE 250. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUGARS AND POLYMERS, 2018-2032 (USD MILLION)
TABLE 251. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2032 (USD MILLION)
TABLE 253. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 254. CHINA ORGANIC PHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Organic Pharmaceutical Excipients market report include:
  • Archer Daniels Midland Company
  • Ashland Global Holdings Inc.
  • Associated British Foods plc
  • BASF SE
  • Cargill Incorporated
  • Croda International Plc
  • DFE Pharma International Ltd.
  • DuPont de Nemours Inc.
  • Evonik Industries AG
  • Gattefossé SAS
  • Ingredion Incorporated
  • Innophos Holdings, Inc.
  • International Flavors & Fragrances Inc.
  • JRS Pharma GmbH & Co. KG
  • Kerry Group Plc
  • Merck KGaA
  • Roquette Frères S.A.
  • Shin-Etsu Chemical Co., Ltd.
  • The Lubrizol Corporation
  • Wacker Chemie AG

Table Information

Report AttributeDetails
No. of Pages194
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 15.09 Billion
Forecasted Market Value ( USD ) by 2032 $ 27.05 Billion
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Pharmaceutical Excipients Market by Product ((Organic (Oleochemicals, Cellulose, Glycols), Inorganic)), Functionality (Fillers & Diluents, Binders, Lubricants), Formulation (Oral, Parenteral), Functionality Application (Stabilizers) - Global Forecast to 2030 - Product Image

Pharmaceutical Excipients Market by Product ((Organic (Oleochemicals, Cellulose, Glycols), Inorganic)), Functionality (Fillers & Diluents, Binders, Lubricants), Formulation (Oral, Parenteral), Functionality Application (Stabilizers) - Global Forecast to 2030

  • Report
  • 633 Pages
  • Global
From
Co-Processed Excipients Market - Global Forecast 2025-2030 - Product Image

Co-Processed Excipients Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Organic Pharmaceutical Excipients Market Report 2025 - Product Image

Organic Pharmaceutical Excipients Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Binders Excipients Market - Global Forecast 2026-2032 - Product Image

Binders Excipients Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Biopharmaceutical Excipients Global Market Report 2025 - Product Image

Biopharmaceutical Excipients Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From

About the Organic Pharmaceutical Excipient Market

Organic Pharmaceutical Excipients are substances used in the production of pharmaceuticals to provide stability, improve bioavailability, and enhance the delivery of active ingredients. They are used in the manufacture of tablets, capsules, and other dosage forms. Excipients are also used to improve the taste, texture, and appearance of pharmaceuticals. They are typically derived from natural sources such as plants, animals, and minerals. Organic Pharmaceutical Excipients are an important part of the Pharmaceutical Intermediates market. They are used to improve the quality and safety of pharmaceuticals, and to ensure that they meet regulatory requirements. Excipients are also used to improve the shelf life of pharmaceuticals, and to reduce the cost of production. Some companies in the Organic Pharmaceutical Excipient market include BASF, Roquette, Ashland, Croda, and Lubrizol. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.